Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Influenza A virus NP/Nucleoprotein Antibody (SAA0410)

Catalog #:   RVV03301 Specific References (50) DATASHEET
Host species: Mouse
Isotype: VHH-mFc
Applications: ELISA, FCM, IF
Accession: Q1K9H2, Q9DLK6
Overview

Catalog No.

RVV03301

Species reactivity

Influenza A virus (strain A/Wilson-Smith/1933 H1N1) (Influenza A virus (strain A/WS/1933 H1N1)), Influenza A virus (A/WSN/1933(H1N1))

Host species

Mouse

Isotype

VHH-mFc

Clonality

Monoclonal

Target

Nucleoprotein, Nucleocapsid protein, Protein N, NP

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q1K9H2, Q9DLK6

Applications

ELISA, FCM, IF

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

SAA0410

Data Image
References

Comparison of whole blood on filter strips with serum for avian influenza virus antibody detection in wild birds., PMID:40491934

No Evidence of Anti-Influenza Nucleoprotein Antibodies in Retail Milk from Across Canada (April-July 2024)., PMID:40474813

Antigenic Characterization of H1N1 Influenza Viruses That Circulated During the 2019-2020 Season in Philadelphia, Pennsylvania., PMID:40452165

M2e/NP Dual Epitope-Displaying Nanoparticles Enhance Cross-Protection of Recombinant HA Influenza Vaccine: A Universal Boosting Strategy., PMID:40333315

Design, Synthesis and In Vivo Evaluation of a Candidate Fusion Epitopic Construct Vaccine Based on M2e, HA1, HA2, NA and NP Fragments of the Highly Pathogenic Avian H5N1 Influenza Virus., PMID:40256578

Evaluation of safety, immunogenicity, and efficacy of inactivated reverse-genetics-based H5N8 highly pathogenic avian influenza virus vaccine with various adjuvants via parenteral and mucosal routes in chickens., PMID:40181968

Fluorescent Microsphere Immunoassay for Isotype-Specific H5N1 Antibody Detection in Serum and Milk Samples From Dairy Cattle: A Tool for Epidemiological Surveillance., PMID:40145266

Characteristics of the First Domestic Duck-Origin H12N8 Avian Influenza Virus in China., PMID:40141383

Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric states., PMID:40139568

Detection of antibodies against influenza A viruses in cattle., PMID:40130892

A novel tetravalent influenza vaccine based on one chimpanzee adenoviral vector., PMID:40023902

Adjuvant-free, self-assembling ferritin nanoparticle vaccine coupled with influenza virus hemagglutinin protein carrying M1 and PADRE epitopes elicits cross-protective immune responses., PMID:39958330

Evaluation of an N1 NA antibody-specific enzyme-linked lectin assay for detection of H5N1 highly pathogenic avian influenza virus infection in vaccinated birds., PMID:39956396

Co-Delivery of Multiple Toll-Like Receptor Agonists and Avian Influenza Hemagglutinin on Protein Nanoparticles Enhances Vaccine Immunogenicity and Efficacy., PMID:39924738

Rapid and specific on-site H5Nx avian influenza diagnosis via RPA and PAM-independent CRISPR-Cas12a assay combined with anti-NP antibody-based viral RNA purification., PMID:39896844

Immunogenicity in mice and non-human primates of an Advax-CpG55.2-adjuvanted recombinant hemagglutinin seasonal quadrivalent influenza vaccine., PMID:39798433

Impact of influenza immune imprinting on immune responses to subsequent vaccinations in mice., PMID:39731808

DDO-adjuvanted influenza A virus nucleoprotein mRNA vaccine induces robust humoral and cellular type 1 immune responses and protects mice from challenge., PMID:39692514

Construction with recombinant epitope-expressing baculovirus enhances protective effects of inactivated H9N2 vaccine against heterologous virus., PMID:39671758

Immunoprotective effect of chitosan nanoparticles with different particle sizes against H9N2 avian influenza infection., PMID:39603189

Highly Pathogenic H5N1 Influenza A Virus (IAV) in Blue-Winged Teal in the Mississippi Flyway Is Following the Historic Seasonal Pattern of Low-Pathogenicity IAV in Ducks., PMID:39599570

Avian influenza virus circulation and immunity in a wild urban duck population prior to and during a highly pathogenic H5N1 outbreak., PMID:39578905

DDO-adjuvanted influenza A virus nucleoprotein mRNA vaccine induces robust humoral and cellular type 1 immune responses and protects mice from challenge., PMID:39553933

Deep mutational scanning of H5 hemagglutinin to inform influenza virus surveillance., PMID:39531474

Dissecting immunological mechanisms underlying influenza viral nucleoprotein-induced mucosal immunity against diverse viral strains., PMID:39508450

Inserting CTL Epitopes of the Viral Nucleoprotein to Improve Immunogenicity and Protective Efficacy of Recombinant Protein against Influenza A Virus., PMID:39452110

Differential detection of SARS-CoV-2 variants and influenza A viruses utilizing a dual lateral flow strip based on colloidal gold-labeled monoclonal antibodies., PMID:39341304

Detection and Monitoring of Highly Pathogenic Influenza A Virus 2.3.4.4b Outbreak in Dairy Cattle in the United States., PMID:39339851

The frequency and function of nucleoprotein-specific CD8+ T cells are critical for heterosubtypic immunity against influenza virus infection., PMID:39082839

Efficacy of commercial recombinant HVT vaccines against a North American clade 2.3.4.4b H5N1 highly pathogenic avian influenza virus in chickens., PMID:39012858

Filling two needs with one deed: a combinatory mucosal vaccine against influenza A virus and respiratory syncytial virus., PMID:38975350

An avian-origin internal backbone effectively increases the H5 subtype avian influenza vaccine candidate yield in both chicken embryonated eggs and MDCK cells., PMID:38970848

Evaluation of Efficacy of Surface Coated versus Encapsulated Influenza Antigens in Mannose-Chitosan Nanoparticle-Based Intranasal Vaccine in Swine., PMID:38932376

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine., PMID:38926455

A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein., PMID:38805853

A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challenge., PMID:38805804

Assessment of CD8+ T-cell mediated immunity in an influenza A(H3N2) human challenge model in Belgium: a single centre, randomised, double-blind phase 2 study., PMID:38729196

Cross-protective efficacy and safety of an adenovirus-based universal influenza vaccine expressing nucleoprotein, hemagglutinin, and the ectodomain of matrix protein 2., PMID:38714444

Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase., PMID:38430907

The protective effect of intranasal immunization with influenza virus recombinant adenovirus vaccine on mucosal and systemic immune response., PMID:38394888

Gold Nanoparticle-Decorated Polymer Particles for High-Optical-Density Immunoassay Probes., PMID:38291580

Thiolated chitosan encapsulation constituted mucoadhesive nanovaccine confers broad protection against divergent influenza A viruses., PMID:38220319

Harnessing preexisting influenza virus-specific immunity increases antibody responses against SARS-CoV-2., PMID:38206036

A Multiseason Randomized Controlled Trial of Advax-Adjuvanted Seasonal Influenza Vaccine in Participants With Chronic Disease or Older Age., PMID:38157402

Equine influenza outbreak in Eastern of Algeria in 2021: The first introduction of Florida Clade 1 to Maghreb area., PMID:38118336

Combinatorial immune refocusing within the influenza hemagglutinin RBD improves cross-neutralizing antibody responses., PMID:38096052

Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or Tofacitinib., PMID:37941436

Efficacy of inactivated and RNA particle vaccines against a North American Clade 2.3.4.4b H5 highly pathogenic avian influenza virus in chickens., PMID:37932132

Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses., PMID:37916834

Nanoparticles Carrying Conserved Regions of Influenza A Hemagglutinin, Nucleoprotein, and M2 Protein Elicit a Strong Humoral and T Cell Immune Response and Protect Animals from Infection., PMID:37764217

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Influenza A virus NP/Nucleoprotein Antibody (SAA0410) [RVV03301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only